SCHEMBL114388

SCHEMBL114388

CCCC(N)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20878304 1.00
Water SCHEMBL4437249 0.97
SCHEMBL9979347 0.97
Hydrochloric Acid SCHEMBL6923489 0.97
Iodide SCHEMBL17593832 0.97
Fluoride SCHEMBL3663570 0.97
Water SCHEMBL14125926 0.97
SCHEMBL1169161 0.81
SCHEMBL9063255 0.80
SCHEMBL1315066 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117979777-A Method for suppressing 1/f noise of detector, perovskite monocrystal and detector 华中科技大学鄂州工业技术研究院 2024-05-03 CN claimed
EP-4297746-A2 COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED COMPOUNDS AND THERAPIES FOR THE TREATMENT OF DISEASES Edison Oncology (US) 2024-01-03 EP claimed
EP-2081430-A2 SALT FORMS OF SUBSTITUTED BENZOTHIENYL COMPOUNDS Janssen Pharmaceutica, N.V. (BE) 2009-07-29 EP claimed
WO-2008051489-A2 SALT FORMS OF SUBSTITUTED BENZOTHIENYL COMPOUNDS JANSSEN PHARMACEUTICA, N.V. (BE) 2008-05-02 WO claimed
CN-1699307-A Large dehydrobenzene ring with functional side chain and its synthesis process UNIV FUDAN (CN) 2005-11-23 CN claimed
EP-1472272-A1 CRYSTALLINE COMPLEXES OF FLUTICASONE 2-FUROATE GLAXO GROUP LIMITED (GB) 2004-11-03 EP claimed
EP-1438316-A1 PHOSPHONIC ACID COMPOUNDS AS INHIBITORS OF SERINE PROTEASES Ortho-McNeil Pharmaceutical, Inc. (US) 2004-07-21 EP claimed
WO-2003066656-A1 CRYSTALLINE COMPLEXES OF FLUTICASONE 2-FUROATE GLAXO GROUP LIMITED (GB) 2003-08-14 WO claimed
WO-2003035654-A1 PHOSPHONIC ACID COMPOUNDS AS INHIBITORS OF SERINE PROTEASES ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2003-05-01 WO claimed
WO-2024100120-A1 REDUCTION OR PREVENTION OF A MALARIA PARASITE OR DENGUE VIRUS TRANSMISSION WITH 1 -METHYL-9H-PYRIDO[3,4-B]INDOLE GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2024-05-16 WO disclosed
WO-2024100131-A1 REDUCING DISEASE TRANSMISSION OF VECTOR BORNE DISEASES GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2024-05-16 WO disclosed
CN-117979777-A Method for suppressing 1/f noise of detector, perovskite monocrystal and detector 华中科技大学鄂州工业技术研究院 2024-05-03 CN disclosed
EP-4355750-A1 PHARMACEUTICAL COMPOUND GlaxoSmithKline Intellectual Property Development Limited (GB) 2024-04-24 EP disclosed
CN-107209146-B Electrochemical gas sensor and electrolyte for electrochemical gas sensor 德尔格安全股份两合公司 2024-03-12 CN disclosed
WO-1997014691-A1 (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES AS COX-2 INHIBITORS MERCK FROSST CANADA INC. (CA) 1997-04-24 WO disclosed
EP-0752990-A1 BENZISOTHIAZOLES DERIVATIVES AS INHIBITORS OF 5-LIPOXYGENASE BIOSYNTHESIS PFIZER INC. (US) 1997-01-15 EP disclosed
WO-1995026346-A1 BENZISOTHIAZOLES DERIVATIVES AS INHIBITORS OF 5-LIPOXYGENASE BIOSYNTHESIS PFIZER INC. (US) 1995-10-05 WO disclosed
EP-0663821-A1 FLUOROCARBON BLOOD SUBSTITUTE SEGEL, Leigh D. (US) 1995-07-26 EP disclosed
US-5374624-A Aqueous emulsion with phospholipid emulsifier SEGEL LEIGH D (US) 1994-12-20 US disclosed
WO-1993002653-A1 FLUOROCARBON BLOOD SUBSTITUTE SEGEL LEIGH D (US) 1993-02-18 WO disclosed